Latest DeCODE genetics Stories
- Nature Published Study Illustrates Value of Big Data Research Methods REYKJAVIK, Iceland, May 5, 2013 /PRNewswire/ -- deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and the University of Iceland reported today in the journal Nature the identification of a rare nonsense mutation that confers high risk of osteoporosis and osteoporosis related...
Lee Rannals for redOrbit.com - Your Universe Online Amgen, a giant biotechnology company, said it plans to pay $415 million to acquire a gene-hunting company. Amgen said on Monday it plans to purchase deCODE Genetics, a company based in Iceland and known for discoveries such as finding that the genetic nature of human disease was far more complex than thought. The two companies hope the deal will be symbolic, as deCODE receives a well-financed partner, and Amgen capitalizes on new...
THOUSAND OAKS, Calif. and REYKJAVIK, Iceland, Dec. 10, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and deCODE Genetics today announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics, a global leader in human genetics, headquartered in Reykjavik, Iceland. The all-cash transaction values deCODE Genetics at $415 million, subject to customary closing adjustments, and was unanimously approved by the Amgen Board of Directors....
REYKJAVIK, Iceland, October 12, 2011 /PRNewswire/ -- deCODE genetics today announced that it has entered into a research collaboration with Pfizer Inc., the objective of which is to discover sequence variants associated with specific clinical phenotypes related to Systemic Lupus Erythematosis by utilizing deCODE's expertise in gene discovery. deCODE's discovery capabilities combine its extensive population and genetic resources, including DNA samples and medical data,...
REYKJAVIK, Iceland, October 9, 2011 /PRNewswire/ -- Scientists at deCODE Genetics and academic collaborators from Iceland, Norway, Denmark, the Netherlands and the USA today report the discovery of low frequency variants in the human genome that associate with risk of gout, a common inflammatory arthritis, and serum uric acid levels. The study was done in collaboration with Illumina, Inc., and is published today in the online edition of Nature Genetics. Using Illumina...
REYKJAVIK, Iceland, October 2, 2011 /PRNewswire/ -- Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain and Finland today report the discovery of variants in the human genome that associate with increased risk of invasive ovarian cancer, one of the deadliest forms of cancer in women. The study was done in collaboration with Illumina, Inc., and is published today in the online edition of Nature Genetics. Using Illumina sequencing...
REYKJAVIK, Iceland, September 25, 2011 /PRNewswire/ -- Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain, Denmark, Germany, Sweden, the USA, the UK and Romania today report the discovery of a variant in the sequence of the human genome associated with risk of developing basal cell carcinoma of the skin (BCC), as well as prostate cancer and glioma, the most serious form of brain cancer. The study was done in collaboration with...
An investigation into direct-to-consumer (DTC) genetic tests found flawed and inaccurate results, with each one giving different results, and in some cases arriving at medical predictions that were no more accurate than flipping a coin, a Dutch study has found. The findings of the study will increase calls for tighter regulations around personalized genetics tests which can cost more than $800. Critics decry the tests as a waste of money that could mislead people about their future health,...
ATLANTA, May 12, 2011 /PRNewswire/ -- EarthLink, Inc. (NASDAQ: ELNK) today announced it has priced its previously announced offering of senior notes. EarthLink is offering $300 million aggregate principal amount of its 8-7/8% senior notes due 2019 to "qualified institutional buyers" as defined in Rule 144A under the Securities Act of 1933 (the "Securities Act") and outside the United States in reliance on Regulation S under the Securities Act. The issue price of the notes will be 96.555%...
REYKJAVIK, Iceland, March 6, 2011 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics and academic colleagues from Iceland, The Netherlands, Denmark, USA and Illumina, Inc., today report the discovery of single-letter variants (SNPs) in the sequence of the human genome associated with high risk of sick sinus syndrome (SSS). The study is published today in the online edition of Nature Genetics. The study reports a genetic variant in the gene MYH6 that is associated with high...
